Latest Insider Transactions at Essa Pharma Inc. (EPIX)
This section provides a real-time view of insider transactions for Essa Pharma Inc. (EPIX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ESSA Pharma Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ESSA Pharma Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 01
2024
|
Growth N V Biotech |
SELL
Open market or private sale
|
Direct |
7,879,583
-52.74%
|
$7,879,583
$1.53 P/Share
|
|
Oct 07
2024
|
Peter Virsik Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
694
-8.19%
|
$4,164
$6.03 P/Share
|
|
Sep 09
2024
|
Peter Virsik Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
694
-7.57%
|
$4,164
$6.0 P/Share
|
|
Sep 03
2024
|
Peter Virsik Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,082
-18.51%
|
$12,492
$6.03 P/Share
|
|
May 06
2024
|
Peter Virsik Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
694
-5.81%
|
$4,164
$6.95 P/Share
|
|
Apr 24
2024
|
Richard M Glickman |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+7.98%
|
$15,000
$4.9 P/Share
|
|
Apr 05
2024
|
Peter Virsik Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
694
-5.49%
|
$4,858
$7.94 P/Share
|
|
Mar 05
2024
|
Peter Virsik Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
694
-5.21%
|
$5,552
$8.98 P/Share
|
|
Feb 06
2024
|
Peter Virsik Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
72,782
-84.52%
|
$727,820
$10.29 P/Share
|
|
Feb 06
2024
|
Peter Virsik Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
72,782
+45.81%
|
$218,346
$3.23 P/Share
|
|
Feb 05
2024
|
Peter Virsik Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,194
-4.28%
|
$10,746
$9.65 P/Share
|
|
Feb 05
2024
|
Peter Virsik Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+3.49%
|
$1,500
$3.23 P/Share
|
|
Jan 16
2024
|
Peter Virsik Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,718
-10.91%
|
$17,180
$10.01 P/Share
|
|
Jan 16
2024
|
Peter Virsik Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,718
+9.84%
|
$5,154
$3.23 P/Share
|
|
Jan 05
2024
|
Peter Virsik Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
699
-4.75%
|
$4,194
$6.11 P/Share
|
|
Dec 14
2023
|
David Ross Parkinson Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
9,223
+12.31%
|
$18,446
$2.3 P/Share
|
|
Nov 21
2023
|
Franklin M Berger |
BUY
Open market or private purchase
|
Direct |
23,259
+2.88%
|
$116,295
$5.73 P/Share
|
|
Nov 06
2023
|
Scott Requadt |
SELL
Other acquisition or disposition
|
Direct |
12,500
-29.41%
|
-
|
|
Nov 03
2023
|
Franklin M Berger |
BUY
Open market or private purchase
|
Direct |
16,471
+2.12%
|
$82,355
$5.99 P/Share
|
|
Nov 02
2023
|
Franklin M Berger |
BUY
Open market or private purchase
|
Direct |
60,000
+7.46%
|
$300,000
$5.35 P/Share
|
|
Oct 30
2023
|
Scott Requadt |
SELL
Other acquisition or disposition
|
Direct |
17,502
-29.17%
|
-
|
|
Dec 30
2022
|
David Ross Parkinson Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,067
+5.15%
|
$6,134
$2.6 P/Share
|
|
Dec 30
2022
|
David S. Wood Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
8,302
+19.94%
|
$16,604
$2.6 P/Share
|
|
Dec 22
2022
|
David Ross Parkinson Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
21,367
+28.55%
|
$42,734
$2.39 P/Share
|
|
Dec 21
2022
|
Franklin M Berger |
SELL
Open market or private sale
|
Direct |
72,223
-4.89%
|
$144,446
$2.42 P/Share
|
|
Dec 20
2022
|
Franklin M Berger |
SELL
Open market or private sale
|
Direct |
43,617
-5.45%
|
$87,234
$2.53 P/Share
|
|
Dec 16
2022
|
Franklin M Berger |
SELL
Open market or private sale
|
Direct |
50,000
-5.88%
|
$100,000
$2.67 P/Share
|
|
Dec 15
2022
|
Franklin M Berger |
SELL
Open market or private sale
|
Direct |
82,000
-4.49%
|
$164,000
$2.88 P/Share
|
|
Dec 14
2022
|
Franklin M Berger |
SELL
Open market or private sale
|
Direct |
25,000
-2.61%
|
$75,000
$3.0 P/Share
|
|
Oct 27
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
500,000
+5.97%
|
$2,000,000
$4.5 P/Share
|
|
Oct 26
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
1,500,000
+16.89%
|
$4,500,000
$3.98 P/Share
|
|
Jul 18
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
300,000
+4.85%
|
$900,000
$3.16 P/Share
|
|
Jul 15
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
241,665
+4.15%
|
$724,995
$3.13 P/Share
|
|
Jul 14
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
347,204
+6.11%
|
$694,408
$2.79 P/Share
|
|
Jun 30
2022
|
David Ross Parkinson Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,887
+13.21%
|
$9,774
$2.96 P/Share
|
|
Apr 27
2022
|
Growth N V Biotech |
SELL
Open market or private sale
|
Direct |
25,100
-0.5%
|
$125,500
$5.85 P/Share
|
|
Aug 18
2021
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
250,000
+4.75%
|
$2,000,000
$8.88 P/Share
|
|
Feb 22
2021
|
Franklin M Berger |
BUY
Open market or private purchase
|
Direct |
57,000
+5.62%
|
$1,539,000
$27.0 P/Share
|
|
Dec 03
2020
|
Franklin M Berger |
BUY
Exercise of conversion of derivative security
|
Direct |
42,207
+0.93%
|
$126,621
$3.94 P/Share
|